EU Healthcare Predictions and Outlook, 2020
EU Healthcare Predictions and Outlook, 2020
Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth
20-Feb-2020
Europe
Market Outlook
Description
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national healthcare policies and regulatory reforms that must re-invigorate future strategies. Social Determinants of Health (SDOH) will emerge as a big theme across progressive health systems as they seek to proactively engage patients and improve health outcomes that would help healthcare organizations meet quality standards.
This decade will bring significant changes and disruptions when it comes to digital-service-enabled health. Health and care delivery, as well as prevention in the 2020s, will become more consumer-centric, with AI-powered tools and virtual interactions between patients and care providers becoming the new normal in many situations. Data-driven interoperability and personalized diagnostics will accelerate the delivery of predictive-analysis-driven precision care. This will pave the way for better and efficient decision making for the patient and the provider and further drive partnerships between big tech companies that design care delivery models and healthcare organizations.
This follows the new vision for healthcare for 2020 and beyond, focusing not only on access, quality, and affordability but also on predictive, preventive, and outcome-based care models that promote social and financial inclusion. In 2020, consumer-driven models of healthcare will gain more market traction, as they stand to better bridge the gap of what consumers want and what healthcare can deliver.
Central and Eastern Europe is highly fragmented and is emerging as quite an attraction to healthcare investors. Screening services are facilitating better diagnosis of chronic conditions. The rise in disposable income and in healthcare spending is because of the presence of a rapidly aging population and their demand for better healthcare. Economic factors are also at play, with rising wages and disposable incomes freeing up personal money for healthcare-related spending. With the recent rise in minimum wages in Hungary and other recent reforms in various parts of Central and Eastern Europe, the economy in CEE and a parallel drop in unemployment rates are ideal for market participants.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
![](https://store.frost.com/infographics/MEE1-01-00-00-00.jpg)
Table of Contents
Market Scope
Geographic Segmentation
Key Questions This Study Will Answer
Top Predictions for the EU Healthcare Industry, 2020
EU Healthcare Industry Forecast by Segment
EU Regional Performance Matrix
Revenue by Region
Prediction#1: By 2020, Orphan Drug R&D Pipeline will Surpass Non-orphan Drug to Account for 55% of the Total Pipeline Value
Prediction#2: Europe will Expand Biomanufacturing Capacity by ~15% to Reach a Market Share of 35% by 2020
Prediction#3: 2020 will be an Inflexion Point for Artificial Intelligence in Europe
Prediction#4: Hospital Cost Saving is Set to Increase by 25%–35% by 2020 as 15%–20% of ORs become Integrated
Prediction#5: POCT Market for Infectious Diseases will Breach the One-billion-dollar Mark in 2020
Prediction#6: Europe will Lead the Global IVF Market in 2020 and Account for 40% of Market Share
Prediction#7: The Demand for Precision Care Procedures will Fuel RASD to Reach $430 million by 2020 and Cut Complication Rates by 10%–15%
Prediction#8: Next-gen Imaging Equipment is set to Yield Annual Operational Savings of 10%–12%
Prediction#9: Medical-grade remote patient monitoring will witness a 15% growth
Prediction#10: Up to 20 New Enterprise-customer Partnerships will Redefine New Business Models
Top Pharmaceuticals and Biotechnology Growth Opportunities
Top Medical Technologies Growth Opportunities
Top Medical Imaging Equipment Growth Opportunities
Top In-Vitro Diagnostics Growth Opportunities
Top Healthcare IT Growth Opportunities
Companies to Watch Out For
Companies to Watch Out for (continued)
Healthcare IT
Medical Technologies
Medical Imaging Equipment
Pharmaceutical & Biotechnology
In-Vitro Diagnostics
UK and Europe’s Interdependencies that Support the Care Continuum
Select Indicators for Health System Assessment
Potential Disruption Across the UK Healthcare Sector
Critical Success Factors
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Growth dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Popular Topics
Deliverable Type | Market Outlook |
---|---|
No Index | No |
Podcast | No |
Author | Bejoy Daniel |
Industries | Healthcare |
WIP Number | MEE1-01-00-00-00 |
Is Prebook | No |
GPS Codes | 9575-B1,9600-B1,9612-B1,9570-B1,9571-B1,9573-B1,9A48-B1,9A4B-B1,9611-B1,9614-B1,9627-B1 |